CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹899 Cr | ₹804 Cr | ₹786 Cr | ₹869 Cr | ₹706 Cr |
What is the latest Total Non-Current Assets ratio of CONCORD BIOTECH ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹899 Cr |
| Mar2024 | ₹804 Cr |
| Mar2023 | ₹786 Cr |
| Mar2022 | ₹869 Cr |
| Mar2021 | ₹706 Cr |
How is Total Non-Current Assets of CONCORD BIOTECH Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹899 Cr | 11.75 | |
| Mar2024 | ₹804 Cr | 2.31 | |
| Mar2023 | ₹786 Cr | -9.54 | |
| Mar2022 | ₹869 Cr | 23.19 | |
| Mar2021 | ₹706 Cr | - | |
Compare Total Non-Current Assets of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹10,873.7 Cr | -5.6% | -5.4% | -36.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -5.6% |
-5.4% |
-36.9% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses